GENE ONLINE|News &
Opinion
Blog

Regulatory
First AI-Guided Ultrasound ECHO Software Approved for Marketing
2020-02-12
Trevena Inc. Gives Oliceridine Approval Another Shot
2020-02-11
Sanofi’s BTK Inhibitor Meets Primary Endpoint in Phase 2 Trial Amidst Criticism
2020-02-07
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
Seqirus’ AUDENZTM, a Vaccine against Potential Flu Epidemic Gets FDA Approval
2020-02-05
R&D
Insmed Soaring High with Positive Phase II Results for Non Cystic Fibrosis Bronchiectasis Drug, INS1007
2020-02-03
FDA Issues Guidances Supporting Development of Gene Therapy Products
2020-02-02
Aimmune’s PALFORZIA™ Scores FDA Win, Becomes the First Ever Treatment For Peanut Allergy
2020-02-01
First Sanofi Designed Investigational Enzyme Replacement Therapy for ASMD Gets Green Signal in Phase II/III Trial
2020-01-31
FDA Greenlights Tepezza as First Treatment for Thyroid Eye Disease
2020-01-22
Weekly Cover: Acepodia’s NK Cell Therapy Drug Candidate ACE1702 Receives FDA Clearance of IND
2020-01-15
Keytruda Flounders Lung Cancer Trial but Scores Key Win for Bladder Cancer
2020-01-14
Bavencio Meets Primary Endpoint in Bladder Cancer Trial
2020-01-09
Ubrelvy Approval, the Best New Year Gift for CGRP Migraine Victims
2020-01-09
Biogen’s BIIB059 May End a 10-Year Drought with New Lupus Drug
2019-12-18
1 48 49 50 51 52 53
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top